Company intelligence / Profile preview

AnnyGod Pharmaceutical

Ownership: Private
Development stage: Other

Overview

AnnyGod Pharmaceutical is a registered Nigerian pharmaceutical company that manufactures and distributes a range of generic medicines. Its portfolio includes commercialized products such as spironolactone and azithromycin. The company is active in the Nigerian market with regulatory listings but does not appear to have novel clinical-stage assets or proprietary platform technologies.

Therapeutic areas: Infectious DiseasesCardiovascular
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on AnnyGod Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnnyGod Pharmaceutical.

Explore the full profile